Clinical Trial Update: A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease [NA]

View source ↗

Summary

A completed clinical trial from the University of British Columbia evaluates a medium-chain triglyceride intervention in Alzheimer's disease and related languag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Frontotemporal Dementia
• Progressive Aphasia

Drugs mentioned

• Medium-chain triglyceride oil (medium-chain triglyceride oil)

Snippet

Sponsor: University of British Columbia | Conditions: Alzheimer's Disease, Primary Progressive Non-fluent Aphasia | NA | Status: COMPLETED